27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Celgene Corporation (NASDAQ: CELG) was added to Bank of America's US 1 List Monday morning, reflecting strong annual revenue and EPS growth.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The firm expects continued strong Revlimid growth momentum and a likely patent settlement, which would remove an overhang. Shares are Buy rated with a $112 price target. This is on the heels of a solid earnings report last week.
Shares of Celgene have moved from $84 on October 16 to all-time highs of $105.25 at time of publication, a 25 percent move.